Drug therapy for neoplastic disease in adults.
D000310:Adrenal Gland Neoplasms / Q000188:drug therapy; D000477:Alkylating Agents / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D000963:Antimetabolites / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy; D002277:Carcinoma / Q000188:drug therapy; D002455:Cell Division / Q000187:drug effects; D002822:Choriocarcinoma / Q000188:drug therapy; D004247:DNA / Q000037:antagonists & inhibitors; D005260:Female; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D007938:Leukemia / Q000188:drug therapy; D008175:Lung Neoplasms / Q000188:drug therapy; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D009101:Multiple Myeloma / Q000188:drug therapy; D011247:Pregnancy; D014565:Urogenital Neoplasms / Q000188:drug therapy; D014747:Vinblastine / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D000477:Alkylating Agents; D000900:Anti-Bacterial Agents; D000963:Antimetabolites; D000970:Antineoplastic Agents; D014750:Vincristine; D014747:Vinblastine; D004247:DNA